SCHEMBL19920107

SCHEMBL19920107

O=CCc1cccc2[nH]ncc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 4/20 0.49
AXL P30530 2/20 0.49
IDO1 P14902 3/20 0.46
METAP2 P50579 1/20 0.45
TDO2 P48775 1/20 0.43
JAK2 O60674 1/20 0.43
JAK1 P23458 1/20 0.43
GLS O94925 2/20 0.41
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1605356 0.83 NOS1 (0.49) NOS1AXLIDO1METAP2TDO2
SCHEMBL24654699 0.83 NOS1 (0.49) NOS1AXLIDO1METAP2TDO2
SCHEMBL28311637 0.80 NOS1 (0.58) NOS1AXLIDO1METAP2TDO2
SCHEMBL2633084 0.80 IDO1 (0.55) NOS1AXLIDO1METAP2TDO2
SCHEMBL12272128 0.77 NOS1 (0.53) NOS1AXLIDO1METAP2TDO2
SCHEMBL6377270 0.77 NOS1 (0.58) NOS1AXLIDO1METAP2TDO2
SCHEMBL14840686 0.77 NOS1 (0.58) NOS1AXLIDO1METAP2TDO2
SCHEMBL20458844 0.77 NOS1 (0.53) NOS1AXLIDO1METAP2TDO2
SCHEMBL30614204 0.77 NOS1 (0.53) NOS1AXLIDO1METAP2TDO2
SCHEMBL29455343 0.77 NOS1 (0.58) NOS1AXLIDO1METAP2TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018039442-A1 TREATMENT OF CANCER WITH INHIBITORS OF GLUTAMINASE CALITHERA BIOSCIENCES, INC. (US) 2018-03-01 WO disclosed